FDA Inspection 1267769 — Zhejiang Chiral Medicine Chemicals Co., Ltd.
The FDA completed an inspection of Zhejiang Chiral Medicine Chemicals Co., Ltd. on Mar 14, 2025 in Hangzhou. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Mar 14, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Hangzhou (China)